Skip to content

Downhill Walking Training in COPD

Downhill Walking to Enhance Training Effects in Patients With COPD

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02113748
Enrollment
42
Registered
2014-04-15
Start date
2014-04-30
Completion date
Unknown
Last updated
2014-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Keywords

Pulmonary disease, chronic obstructive, Downhill walking, exercise

Brief summary

This randomized control trial will investigate whether a modality that generates more contractile muscle fatigue with lower ventilatory requirements render better results after a 12-week exercise training program in subjects with COPD. Subjects will be randomized to either exercise in a training program including downhill walking or to exercise in a training program including conventional walking.

Interventions

Walk on a treadmill with a negative inclination.

Walk on a treadmill without inclination. Possible to progress training intensity with positive inclinations

Sponsors

Research Foundation Flanders
CollaboratorOTHER
Conselho Nacional de Desenvolvimento Científico e Tecnológico
CollaboratorOTHER_GOV
KU Leuven
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients with a primary diagnosis of COPD according to internationally accepted guidelines * Patients referred to the outpatient PR program of Gasthuisberg University Hospital(Leuven, Belgium)

Exclusion criteria

* Any underlying disease or musculoskeletal limitation that could impair the ability to perform any of the exercise training modalities * Absence of exacerbations in the previous month before entering the present study * Patients included on the waiting list for lung transplantation

Design outcomes

Primary

MeasureTime frame
changes in 6-minute walking distancechanges from baseline to Week 12

Countries

Belgium

Contacts

Primary ContactThierry Troosters, PhD
Thierry.Troosters@kuleuven.be

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026